RxDoctor Payments Data

Michael Milshteyn, MD

Orthopaedic Surgery · Saint Paul, MNNPI 1427318005

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (34.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Arthrex at 57.3% of the total. Reporting peaked in 2023 at $18,315 and has fallen 61.9% since, to $6,969 in 2025.

$63,810in general payments, 2019–2025

Across 277 payments — averaging $230.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$37K
  • Pinnacle, Inc$22K
  • Stryker$2K
  • Smith+Nephew$2K
  • Johnson & Johnson$538
  • Kerecis Limited$235
  • plus $1K from 17 others

What the payments were for

  • Speaking & faculty fees$22,25035%
  • Travel & lodging$10,78817%
  • Food & beverage$9,44215%
  • Education$21,33133%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$63,810 in reported general payments places this provider in the 85th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota →

Medicare billing

Part B allowed, 2024
$110,678
Medicare patients
149
Services billed
485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam13$130
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$84
Tramadol Hcl15$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Saint Paul

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →